Multibagger Healthcare Stock Hiting Back-to-Back Upper Circuit: Company Sets Foot in Southeast Asia with New Singapore Subsidiary to Target $15.1 Billion Nutraceutical Market

Multibagger Healthcare Stock Hiting Back-to-Back Upper Circuit: Company Sets Foot in Southeast Asia with New Singapore Subsidiary to Target $15.1 Billion Nutraceutical Market

DSIJ Intelligence-2

In the last 12 months, the stock has given multibagger returns of 739 per cent.

Aayush Wellness Limited, an integrated healthcare company dedicated to holistic wellness and innovation, is pleased to announce that its Board of Directors has approved the formation of a wholly owned subsidiary in Singapore with an initial capital investment of SGD 10,000.

DSIJ offers a service 'Pop BTST" with recommendations for intraday stocks for tomorrow based on research and analysis to help subscribers make healthy profits. If this interests you, download the service details pdf here

This strategic expansion marks a significant step in the company’s global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets.

Mr. Naveena Kumar, Managing Director of Aayush Wellness said “Our new Singapore-based subsidiary will enable us to tap into one of the world’s most dynamic wellness markets, offering greater agility in operations, regulatory efficiency, and direct access to high-growth ASEAN economies. This is a critical step toward building a global wellness brand.”

The stock has now hit consecutive upper circuits for 30 straight trading sessions. Moreover, it has maintained a winning streak for 47 sessions in a row. During this period, the stock has surged from Rs 55 to Rs 151, moving from double digits to triple digits. In the last 12 months, the stock has given multibagger returns of 739 per cent. In the longer time period of 5-years the stock has given 5,500 per cent multibagger returns. 

Unlocking Regional Potential: 

The Southeast Asian nutraceutical market is projected to reach USD 15.1 billion by 2028, growing at a CAGR of 7.5%, driven by rising health consciousness, urbanisation, and preference for preventive healthcare solutions. 

Singapore, in particular, stands out as a key market and gateway for regional expansion. The country’s nutraceutical sector is valued at over USD 1.3 billion, with steady growth driven by an aging population, high per capita health spending, and a consumer base that actively seeks functional foods, dietary supplements, and herbal wellness solutions. Its strong regulatory framework and international connectivity make it an ideal base for Aayush Wellness’s global ambitions.

Key Focus Areas of the Subsidiary:

  • Localising product offerings to align with regulatory and cultural preferences.
  • Forging strategic partnerships and e-commerce distribution channels across ASEAN.
  • Driving export growth from India while expanding the company’s international brand presence.
  • Establishing a regional R&D and innovation hub to adapt to market-specific wellness trends.

Aligned with Aayush Wellness’s Vision:

This development is in line with Aayush Wellness Limited’s broader mission to deliver science-backed, sustainable, and natural healthcare solutions globally. The company aims to use its new presence in Singapore to not only access markets in Malaysia, Indonesia, Thailand, and Vietnam, but also to establish a foundation for future global partnerships and innovation.

Disclaimer: The article is for informational purposes only and not investment advice.

Previous Article Indian Markets Trade Flat as Financials Drag; IT and Broader Indices Hold Gains Amid Global Optimism
Next Article Rs 5,79,100 Crore Order Book: Civil Construction Company Secures Over Rs 5,000 Crore Orders for Power Transmission & Distribution Projects in India and Middle East
Rate this article:
4.5

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR